| povidone-iodine 75 MG/ML Topical Solution |
SCD |
| povidone-iodine 75 MG/ML Topical Solution |
SCD |
| povidone-iodine 75 MG/ML Topical Solution |
SCD |
| povidone-iodine 75 MG/ML Topical Solution |
SCD |
| povidone-iodine 75 MG/ML Topical Solution |
SCD |
| povidone-iodine 75 MG/ML Topical Solution |
SCD |
| povidone-iodine 75 MG/ML Topical Solution |
SCD |
| povidone-iodine 75 MG/ML Topical Solution |
SCD |
| povidone-iodine 75 MG/ML Topical Solution |
SCD |
| povidone-iodine 75 MG/ML Topical Solution [Triadine] |
SBD |
| povidone-iodine 75 MG/ML Topical Solution [Triadine] |
SBD |
| povidone-iodine 75 MG/ML Topical Solution [Triadine] |
SBD |
| povidone-iodine 75 MG/ML Topical Solution [Triadine] |
SBD |
| povidone-iodine 8.3 % / isopropyl alcohol 72.5 % Topical Solution |
PSN |
| povidone-iodine gel 10 % Medicated Pad |
PSN |
| povidone-iodine gel 10 % Medicated Pad |
PSN |
| povidone-iodine gel 10 % Medicated Pad |
PSN |
| povidone-iodine gel 10 % Medicated Pad |
PSN |
| povidone-iodine gel 10 % Medicated Pad |
PSN |
| povidone-iodine gel 10 % Medicated Pad |
PSN |
| pozelimab-bbfg 400 MG in 2 ML Injection |
PSN |
| pozelimab-bbfg 400 MG per 2 ML Injection |
SY |
| prabotulinumtoxinA-xvfs 100 UNT Injection |
PSN |
| prabotulinumtoxinA-xvfs 100 UNT Injection |
SCD |
| prabotulinumtoxinA-xvfs 100 UNT Injection [Jeuveau] |
SBD |
| Pradalex 200 MG/ML Injectable Solution |
PSN |
| Pradalex 200 MG/ML Injectable Solution |
SY |
| Pradaxa 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule |
SY |
| Pradaxa 110 MG Oral Capsule |
PSN |
| Pradaxa 110 MG Oral Capsule |
SY |